ATE555783T1 - Mittel zur behandlung oder prävention von ischämischer neuropathie - Google Patents
Mittel zur behandlung oder prävention von ischämischer neuropathieInfo
- Publication number
- ATE555783T1 ATE555783T1 AT04799962T AT04799962T ATE555783T1 AT E555783 T1 ATE555783 T1 AT E555783T1 AT 04799962 T AT04799962 T AT 04799962T AT 04799962 T AT04799962 T AT 04799962T AT E555783 T1 ATE555783 T1 AT E555783T1
- Authority
- AT
- Austria
- Prior art keywords
- agents
- treating
- preventing ischemic
- ischemic neuropathy
- independently hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/86—Oxygen atoms, e.g. xanthones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/11—Preparation or pretreatment of starting material involving culturing conditions, e.g. cultivation in the dark or under defined water stress
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003406804 | 2003-12-05 | ||
| PCT/JP2004/018114 WO2005053678A1 (ja) | 2003-12-05 | 2004-11-30 | 虚血性神経障害治療又は予防剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE555783T1 true ATE555783T1 (de) | 2012-05-15 |
Family
ID=34650292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04799962T ATE555783T1 (de) | 2003-12-05 | 2004-11-30 | Mittel zur behandlung oder prävention von ischämischer neuropathie |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20070105948A1 (de) |
| EP (1) | EP1693060B1 (de) |
| JP (1) | JP4820170B2 (de) |
| KR (1) | KR20070029123A (de) |
| AT (1) | ATE555783T1 (de) |
| ES (1) | ES2382808T3 (de) |
| WO (1) | WO2005053678A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011025775A1 (en) * | 2009-08-24 | 2011-03-03 | Alterman Ron L | Apparatus for trans-cerebral electrophoresis and methods of use thereof |
| US9040062B2 (en) | 2010-08-06 | 2015-05-26 | Sumitomo Dainippon Pharma Co., Ltd. | Preparation for treatment of spinal cord injury |
| CA2827869C (en) | 2011-02-25 | 2019-04-02 | Dainippon Sumitomo Pharma Co., Ltd. | Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient |
| JP6742343B2 (ja) | 2016-01-15 | 2020-08-19 | 大日本住友製薬株式会社 | 2環性複素環化合物 |
| JP7551502B2 (ja) * | 2018-12-12 | 2024-09-17 | 住友ファーマ株式会社 | 新規投与方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0580609A1 (de) * | 1991-03-22 | 1994-02-02 | Xenova Limited | Pharmazeutische xanthonderivate |
| US5266580A (en) * | 1992-01-24 | 1993-11-30 | Texas A&M University System | Treatment of low pressure glaucoma and ischemic retinal degeneration with droperidol |
| JPH08165237A (ja) * | 1994-12-12 | 1996-06-25 | Bio Kosumosu:Kk | 血液流動性改善剤 |
| WO2002009756A1 (en) * | 2000-07-28 | 2002-02-07 | Sumitomo Pharmaceuticals Company, Limited | Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient |
| JP4633897B2 (ja) * | 2000-08-17 | 2011-02-16 | 長瀬産業株式会社 | 神経突起伸長剤 |
| WO2003062440A1 (en) * | 2002-01-21 | 2003-07-31 | Sumitomo Pharmaceuticals Co., Ltd. | Xanthone derivative |
| EP1475382B1 (de) * | 2002-01-24 | 2008-12-10 | Dainippon Sumitomo Pharma Co., Ltd. | Verbindungen als semaphorininhibitoren |
-
2004
- 2004-11-30 ES ES04799962T patent/ES2382808T3/es not_active Expired - Lifetime
- 2004-11-30 US US10/581,663 patent/US20070105948A1/en not_active Abandoned
- 2004-11-30 EP EP04799962A patent/EP1693060B1/de not_active Expired - Lifetime
- 2004-11-30 KR KR1020067012899A patent/KR20070029123A/ko not_active Ceased
- 2004-11-30 WO PCT/JP2004/018114 patent/WO2005053678A1/ja not_active Ceased
- 2004-11-30 AT AT04799962T patent/ATE555783T1/de active
- 2004-11-30 JP JP2005516014A patent/JP4820170B2/ja not_active Expired - Fee Related
-
2010
- 2010-11-05 US US12/940,498 patent/US20110105599A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP4820170B2 (ja) | 2011-11-24 |
| EP1693060A1 (de) | 2006-08-23 |
| US20070105948A1 (en) | 2007-05-10 |
| KR20070029123A (ko) | 2007-03-13 |
| WO2005053678A1 (ja) | 2005-06-16 |
| US20110105599A1 (en) | 2011-05-05 |
| ES2382808T3 (es) | 2012-06-13 |
| EP1693060A4 (de) | 2008-09-17 |
| JPWO2005053678A1 (ja) | 2007-06-28 |
| EP1693060B1 (de) | 2012-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0225475D0 (en) | Therapeutic agents | |
| GB0225474D0 (en) | Therapeutic agents | |
| GB0318447D0 (en) | Therapeutic agents | |
| GB0223038D0 (en) | Therapeutic compounds | |
| CY1110901T1 (el) | Στερεοϊσομερεις ενωσεις και μεθοδοι για την αγωγη γαστρεντερικων διαταραχων και διαταραχων του κεντρικου νευρικου συστηματος | |
| NO20062691L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| IL173396A0 (en) | Piperazine derivatives and their use as therapeutic agents | |
| DE60026155D1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
| DE60314633D1 (de) | Substituierte 1,3-diphenylprop-2-en-1-on derivate, deren herstellung und anwendungen | |
| UY28011A1 (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos | |
| DE60119784D1 (de) | Cyclische salen metall verbindungen als einfänger von sauerstoffradikalen und verwendbar als antioxidantien bei der behandlung und vorbeugung von krankheiten | |
| BR0309278A (pt) | Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto | |
| WO2004110380A3 (en) | Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents | |
| NO20064282L (no) | Morfolinforbindelser | |
| GB0207495D0 (en) | Organic compounds | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| SE0400043D0 (sv) | New compounds | |
| BRPI0416720B8 (pt) | composto, processo para a preparação de um composto, composição fungicida e método de combate curativo ou preventivo dos fungos fitopatogênicos de culturas | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| ATE556712T1 (de) | A2a antagonisten zur behandlung von motorischen störungen | |
| BR0306855A (pt) | Método para o tratamento de distúrbios cognitivos | |
| ECSP066484A (es) | Compuestos y metodos para el tratamiento de dislipidemia | |
| ATE555783T1 (de) | Mittel zur behandlung oder prävention von ischämischer neuropathie | |
| MY147404A (en) | Process for preparation of n-benzoyl-staurosporine | |
| AU2003213661A8 (en) | Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |